SAGE Therapeutics to Present at 33rd Annual J.P. Morgan

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SAGE Therapeutics to Present at 33rd Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 5, 2015 (GLOBE NEWSWIRE) -- SAGE Therapeutics (Nasdaq: SAGE ), a clinical-stage biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced that Jeffrey Jonas, M.D., chief executive officer, is scheduled to present a company overview and update at the 33rd Annual J.P. Morgan Healthcare Conference at 11:30 a.m. PT on Monday, January 12, 2015 at the Westin St. Francis Hotel in San Francisco.

A live webcast of the presentation can be accessed by visiting the investors section of SAGE's website at investor.sagerx.com . A replay of the webcast will also be archived on SAGE's website following the presentation.

About SAGE Therapeutics

SAGE Therapeutics (Nasdaq: SAGE ) is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system, or CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus, or SRSE, and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders. For more information, please visit www.sagerx.com .

Media Contact: Dan Budwick, Pure Communications 973-271-6085 Investor Contact: Monique Allaire Lyons, Pure Communications 781-631-0759

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 17

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 497

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 336

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 710

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 642

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 98

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 9

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Comerica Reaffirms Board Leadership and Future Strategies

Updated Category News Views 220

Comerica Shares Latest Developments on Shareholder Meeting Comerica Incorporated (NYSE: CMA) recently held its annual shareholders' meeting, where significant decisions were made regarding its leadership and future directions. The event served as a platform to express the company's dedication to elevating shareholder value and ensuring long-term growth. Election of Board...

Continue Reading
UCLOUDLINK GROUP INC. Financial Results Conference Call Details

Updated Category News Views 106

UCLOUDLINK GROUP INC. to Report Financial Results Soon UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), recognized as the world’s pioneering mobile data traffic sharing marketplace, has announced a significant event coming up. The Company is set to disclose its unaudited financial results for the third quarter concluded September 30 shortly...

Continue Reading
Umecrine Cognition Secures Major Grant for Parkinson's Research

Updated Category News Views 320

Umecrine Cognition's Breakthrough in Parkinson's Research Karolinska Development AB, listed on Nasdaq Stockholm under the ticker KDEV, is proud to announce that its portfolio company, Umecrine Cognition, has received a significant boost in its research endeavors. Supported by a generous grant from The Michael J. Fox Foundation, totaling USD 420,000, Umecrine Cognition...

Continue Reading
Corey Sanders Steps Down as COO of MGM Resorts After 30 Years

Updated Category News Views 222

Corey Sanders Announces Retirement from MGM Resorts After an impressive tenure spanning over three decades, Corey Sanders, the Chief Operating Officer of MGM Resorts International (NYSE: MGM), has decided to retire. His departure symbolizes the end of an era for one of the leading figures in the hospitality and entertainment industry. Sanders has played a pivotal role in...

Continue Reading
Neill Tipton Strengthens Core4ce Advisory Board with Expertise

Updated Category News Views 49

Neill Tipton Joins Core4ce’s Board of Advisors Core4ce, a prominent federal contractor known for its work in data and cyber operations, is excited to announce the addition of Neill Tipton to its Board of Advisors. With more than 40 years of experience in intelligence and national security, Tipton brings a rich background and strong leadership that will elevate the...

Continue Reading